The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Framomycin 150 mg/ml Solution for Injection

150 milligram(s)/millilitre Solution for injection

Elanco GmbHVPA22020/025/001

Main Information

Trade NameFramomycin 150 mg/ml Solution for Injection
Active SubstancesFramycetin sulphate
Strength150 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderElanco GmbH
Licence NumberVPA22020/025/001

Group Information

ATC CodeQJ01GB Other aminoglycosides
Therapeutic ClassAntibacterial


Licence Issued22/04/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back